Novus Biologicals products are now on bio-techne.com

TRAF-6 Inhibitor Peptide Set

Images

 
TRAF6 Inhibitor Peptide Set [NBP2-26506] - The TRAF6 inhibitory peptide inhibits osteoclast ifferentiation: RAW264.7 cells were plated on 24-well plates and stimulated with RANKL and M-CSF and incubated in the presence ...read more

Product Details

Summary
Reactivity Hu, Mu, RtSpecies Glossary
Applications Func, B/N
Concentration
LYOPH

Order Details

Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

TRAF-6 Inhibitor Peptide Set Summary

Immunogen
Functions as a TRAF6 decoy by binding to the T6DP motif of RANK, thereby preventing binding of RANK to TRAF6.
Specificity
The TRAF6 inhibitory peptide also contains a protein transduction (PTD) sequence (DRQIKIWFQNRRMKWKK) derived from antennapedia which renders the peptide cell permeable. The control peptide consists of only the PTD sequence.
Preparation
Method
Preparation of 5 mM Stock Solutions
PBS* is added directly to the vials to prepare the stock solutions. Note: Bring the solution to room temperature and quick spin the tubes before opening the caps.

TRAF6 Inhibitor Peptide: 1 mg of DRQIKIWFQNRRMKWKKRKIPTEDEY
Add 57.7 ul of PBS* to the vial to make a 5 mM stock solution. Mix by vortexing. Aliquot and store at -20C or -80C. Avoid repeated freeze thawing.

Control Peptide: 1 mg of DRQIKIWFQNRRMKWKK
Add 84.8 ul PBS* to the vial. Mix by vortexing. Aliquot and store at 20C or -80C. Avoid repeated freeze thawing.


*Recipe for 1X PBS:
1. Dissolve the following in 800ml distilled H2O.
- 8g of NaCl
- 0.2g of KCl
- 1.44g of Na2HPO4
- 0.24g of KH2PO4
2. Adjust pH to 7.5 with HCl.
3. Adjust volume to 1L with additional distilled H2O.
4. Sterilize by autoclaving
Content
TRAF6 Inhibitor peptide: 2 x 1 mg (lyophilized) DRQIKIWFQNRRMKWKKRKIPTEDEY (TRAF6 binding sequence: RKIPTEDEY). Molecular weight: 3494. Antennapedia Control peptide: 2 x 1 mg (lyophilized) DRQIKIWFQNRRMKWKK. Molecular weight: 2361.
Gene
TRAF6

Applications/Dilutions

Dilutions
  • Block/Neutralize reported in scientific literature (PMID 24829345)
  • In vitro assay reported in scientific literature (PMID 24829345)
Application Notes
Inhibition of RANKL mediated osteoclast differentiation.

Researchers can study the effect of TRAF6 inhibitor peptide using a variety of methods, such as EMSA, NF-kB/p65 ELISA,IkBa phosphorylation ELISA, osteoclast differentiation assay. The Osteoclast formation assay protocol is a guideline which may need to be optimized for different cell types.
Publications
Read Publications using
NBP2-26506 in the following applications:

Packaging, Storage & Formulations

Storage
Store at -20C. Avoid freeze-thaw cycles.
Buffer
Form: White Solid

Solubilize the peptides prior to use by making 5 mM PBS* stock solutions (please see Preparation of 5 mM Stock Solutions under Preparation Method).
Concentration
LYOPH
Reconstitution Instructions
Please contact technical support for detailed reconstitution instructions.

Alternate Names for TRAF-6 Inhibitor Peptide Set

  • E3 ubiquitin-protein ligase TRAF6
  • EC 6.3.2.-
  • Interleukin-1 signal transducer
  • RING finger protein 85
  • RNF85MGC:3310
  • TNF receptor-associated factor 6
  • TRAF6
  • TRAF-6

Background

TRAF6 is an adapter protein that links RANK with downstream signaling molecules, and plays a key role in RANKL mediated osteoclast differentiation. RANK contains a novel TRAF6-binding motif (T6DP) through which it binds to TRAF6 upon activation by RANKL. The TRAF6 inhibitory peptide contains a sequence from the T6DP motif of mouse RANK. The peptide binds to RANK, blocking TRAF6 and RANK interaction and thereby inhibiting osteoclast differentiation.

The TRAF6 inhibitory peptide also contains a protein transduction (PTD) sequence (DRQIKIWFQNRRMKWKK) derived from antennapedia which renders the peptide cell permeable.The control peptide consists of only the PTD sequence

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Inhibitors are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

NB100-56583
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, WB
NB100-56173
Species: Hu
Applications: Flow, ICC/IF, IHC, IHC-P, IP, WB
NB100-56566
Species: Bv, Hu, Ma, Mu, Po, Rt
Applications: B/N, ChIP, CyTOF-ready, DB, Dual ISH-IHC, ELISA(Cap), ELISA, Flow-CS, Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, In vitro, KD, KO, PAGE, WB
NB100-56508
Species: Av, Hu, Mu, Rt
Applications: CyTOF-ready, Flow-CS, Flow, IHC, IHC-P, WB
NBP1-77068
Species: Hu, Mu, Rt
Applications: ELISA, ICC/IF, IP, WB
462-TEC
Species: Mu
Applications: BA
NBP2-29328
Species: Bv, Hu, Mu, Rt, Xp, Ye, Ze
Applications: BindInhib, B/N, ELISA, Flow, Func-Inh, IHC, In vitro, In vivo
MAB17761
Species: Hu, Mu, Rt
Applications: ICC, WB
201-LB
Species: Hu
Applications: BA
NB100-56144
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, IP, WB
M6000B
Species: Mu
Applications: ELISA
MAB8930
Species: Hu
Applications: ICC, Simple Western, WB
NB100-56176
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, IP, WB
AF1230
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
NB100-56363
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB
NB100-56722
Species: Ca, Hu, Mu, Rb, Rt
Applications: B/N, DB, ELISA, Flow-CS, Flow, Func, ICC/IF, IP, In vitro, WB
AF632
Species: Hu
Applications: AgAct, Simple Western, WB
PP-H0107B-00
Species: Hu
Applications: DirELISA, IHC, IP, WB
NBP2-50037
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, KO, WB
Supplier Logo

Publications for TRAF-6 Inhibitor (NBP2-26506)(19)

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 4 applications: B/N, Func, In vitro, WB.


Filter By Application
B/N
(4)
Func
(1)
In vitro
(1)
WB
(1)
All Applications
Filter By Species
Human
(2)
Mouse
(5)
All Species
Showing Publications 1 - 10 of 19. Show All 19 Publications.
Publications using NBP2-26506 Applications Species
Fabian Giehler, Michael S. Ostertag, Thomas Sommermann, Daniel Weidl, Kai R. Sterz, Helmut Kutz, Andreas Moosmann, Stephan M. Feller, Arie Geerlof, Brigitte Biesinger, Grzegorz M. Popowicz, Johannes Kirchmair, Arnd Kieser Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex Nature Communications 2024-01-10 [PMID: 38195569]
Kondegowda NG, Filipowska J, Do JS et al. RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes Science advances 2023-11-03 [PMID: 37910614]
Halpin JC, Whitney D, Rigoldi F et al. Molecular determinants of TRAF6 binding specificity suggest that native interaction partners are not optimized for affinity Protein science : a publication of the Protein Society 2022-11-01 [PMID: 36305766]
Pushalkar S, Hundeyin M, Daley D et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018-03-22 [PMID: 29567829] (B/N, Mouse) B/N Mouse
Biswas S, Zimman A, Gao D et al. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated with Hyperlipidemia Circ. Res. 2017-08-03 [PMID: 28775078] (B/N, Mouse) B/N Mouse
Wu DJ, Gu R, Sarin R et al. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis. J. Autoimmun. 2016-06-18 [PMID: 27330028] (Mouse) Mouse
Hou W, Jin YH, Kang HS, Kim BS. IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. J. Virol. 2014-05-14 [PMID: 24829345] (In vitro, B/N, Mouse)

Details:
Mouse bone marrow cells, Fig 7C. Cells were treated with 100 uM TRAF6 inhibitory or control peptides prior to cytokine stimulation.
In vitro, B/N Mouse
Giehler F, Ostertag M, Sommermann T et al. Epstein-Barr virus-driven B cell lymphoma mediated by a unique LMP1-TRAF6 complex Research Square 2022-02-04
Meng Y, Liu C, Shen L et al. TRAF6 mediates human DNA2 polyubiquitination and nuclear localization to maintain nuclear genome integrity Nucleic Acids Res. 2019-06-19 [PMID: 31216032] (B/N) B/N
kisiswa L, Fernandez-Suarez D, Sergaki MC, Ibanez CF. RIP2 Gates TRAF6 Interaction with Death Receptor p75NTR to Regulate Cerebellar Granule Neuron Survival. Cell Rep. 2018-07-24 [PMID: 30044969] (WB, Mouse) WB Mouse
Show All 19 Publications.

Reviews for TRAF-6 Inhibitor (NBP2-26506) (0)

There are no reviews for TRAF-6 Inhibitor (NBP2-26506). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

View specific protocols for TRAF-6 Inhibitor (NBP2-26506): Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for TRAF-6 Inhibitor (NBP2-26506) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional TRAF-6 Products

Research Areas for TRAF-6 Inhibitor (NBP2-26506)

Find related products by research area.

Blogs on TRAF-6

There are no specific blogs for TRAF-6, but you can read our latest blog posts.
Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our TRAF-6 Inhibitor Peptide Set and receive a gift card or discount.

Bioinformatics

Gene Symbol TRAF6